Prosecution Insights
Last updated: October 27, 2026

Andrew J Mensh, USPTO Patent Examiner

Listed by the USPTO as MENSH, ANDREW J

Tech Center 6200 • Art Units: 3761 3781 6221

This examiner grants 64% of resolved cases

Analysis

MENSH, ANDREW J is assigned to Tech Center 6200 and Art Unit 3761. The record contains 602 resolved cases, with an allowance rate of 64.5% and a median time to allowance of 1292 days. The interview lift is 19.2%, so an interview is a relevant but not exclusive prosecution tool. The timing data supports early consideration of claim scope, response sequencing, and the cost of extended examination.

The listed companies are PureWick Corporation, Smith & Nephew plc, and Alcon Inc. The listed firms are Knobbe, Martens, Olson & Bear, LLP, Cole Schotz, P.C., and COLLARD & ROE, P.C. Practitioners can use these recurring entities to find comparable medical technology matters and to prepare interview positions that address the particular references and limitations in the application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

64.5%
Allow Rate
+4.5% vs TC avg
639
Total Applications
+19.2%
Interview Lift
1292
Avg Prosecution Days
Based on 602 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
13.8%
§102 Novelty
59.6%
§103 Obviousness
16.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18697377 ADHERENCE MONITORING SYSTEM AND METHOD Final Rejection The Regents of the University of Michigan
18805420 APPARATUS, SYSTEM AND METHOD FOR CORNEAL BIOMECHANICS DIAGNOSTICS Non-Final OA Alcon Inc.
18844364 METHOD AND SYSTEM FOR DELIVERY OF THERAPEUTICS TO EYE Non-Final OA The Johns Hopkins University
19336208 WOUND DRESSING AND METHOD OF USE Final Rejection Smith & Nephew PLC
18848362 DISTRIBUTED NEGATIVE PRESSURE WOUND THERAPY SYSTEMS AND METHODS Non-Final OA T.J.Smith and Nephew,Limited
18285563 INTELLIGENT DISPOSABLE DEVICES FOR WOUND THERAPY AND TREATMENT Non-Final OA T.J.Smith and Nephew,Limited
18414408 Retainer System for Catheter Final Rejection C. R. Bard, Inc.
18418554 BLOOD PURIFICATION APPARATUS Non-Final OA NIKKISO COMPANY LIMITED
18754255 COVER LAYER FOR A DISPOSABLE HYGIENE ARTICLE, AND DISPOSABLE HYGIENE ARTICLE Non-Final OA Nitto Denko Corporation
19039165 APPARATUS AND METHODS FOR RECEIVING DISCHARGED URINE Non-Final OA PUREWICK CORPORATION
18376274 APPARATUS AND METHODS FOR RECEIVING DISCHARGED URINE Final Rejection PUREWICK CORPORATION
18115444 APPARATUS AND METHODS FOR RECEIVING DISCHARGED URINE Non-Final OA PureWick Corporation
17909776 SYSTEM AND METHOD FOR OPENING A CONCENTRATE CONTAINER AND CONNECTING THE CONCENTRATE CONTAINER TO A BLOOD TREATMENT DEVICE Final Rejection FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
18379318 SYSTEM FOR VACUUM SUCTION AND IRRIGATION OF WOUNDS Final Rejection J&M Shuler Medical Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Andrew J Mensh's allowance rate?

64.5% of resolved applications examined by Andrew J Mensh were allowed (602 resolved cases), compared with 57.7% across Art Unit 3761 over the last five years.

Does an interview help with examiner Andrew J Mensh?

This examiner's interview lift is +19.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Andrew J Mensh take to allow a patent?

Applications allowed by Andrew J Mensh took 1,292 days on average from filing to allowance.

Which art unit does examiner Andrew J Mensh work in?

Andrew J Mensh examines applications in Art Unit 3761 in Tech Center 6200.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month